HACKENSACK, N.J., Dec. 10, 2018 /PRNewswire/ -- Champions
Oncology, Inc. (Nasdaq: CSBR), engaged in an end-to-end range of
research and development technology solutions and services to
improve the development and use of oncology drugs, today announced
it will report its financial and operational results for the second
quarter ended October 31, 2018, on
Monday, December 17, 2018.
The company will host a conference call to discuss the second
quarter results that day at 4:30 p.m.
EST (1:30 p.m. PST). To
participate in the call, please call 877-407-8035 (domestic) or
201-689-8035 (international) ten minutes ahead of the call and give
the verbal reference "Champions Oncology."
A replay of the call will be available by dialing 877-481-4010
or 919-882-2331 and entering Passcode: 41544, or by accessing the
Investor tab of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology, Inc. is engaged in an end-to-end range of
research and development technology solutions and services to
improve the development and use of oncology drugs. The Company's
TumorGraft technology platform is a novel approach to personalizing
cancer care based upon the implantation of primary human tumors in
immune deficient mice followed by propagation of the resulting
engraftments, or TumorGrafts, in a manner that preserves the
biological characteristics of the original human tumor in order to
determine the efficacy of a treatment regimen. The Company
uses this technology in conjunction with related services to offer
solutions for two customer groups: Personalized Oncology
Solutions, in which results help guide the development of
personalized treatment plans, and Translational Oncology Solutions,
in which pharmaceutical and biotechnology companies seeking
personalized approaches to drug development can lower the cost and
increase the speed of developing new drugs. TumorGrafts are
procured through agreements with a number of institutions in the
U.S. and overseas as well as through Champions' Personalized
Oncology Solutions business. For more information, please visit
www.championsoncology.com.
View original
content:http://www.prnewswire.com/news-releases/champions-oncology-to-announce-second-quarter-financial-results-on-monday-december-17-2018-300762726.html
SOURCE Champions Oncology, Inc.